Top Markets
#1 Akedo Akedo +69.97%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.06%
#4 Cross Cross +36.90%
#5 Velvet Velvet +31.95%
#6 Black Phoenix Black Phoenix +26.64%
#7 Cap Cap +22.61%
#8 OVERTAKE OVERTAKE +19.97%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.79%
#10 Ontology Gas Ontology Gas +11.65%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
株式のランク #39100
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
株価
$0.02243487
最終同期: 2025-06-04
時価総額
$650.09K
変化（1日）
0.39%
変化（1年）
0.00%
国
SE
取引 Lipidor AB (publ) (LIPI)

カテゴリー

Healthcare
Lipidor AB (publ)（LIPI）の発行済株式数
December 2024 時点の発行済株式数 251.84M
Lipidor AB (publ) の最新の財務報告および株価によると、現在の発行済株式数は 251.84M です。December 2023 の終わりには、同社は 28.98M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Lipidor AB (publ)（LIPI）の発行済株式数の履歴（2016 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 251.84M -41.77%
2024 432.53M 1,392.66%
2023 28.98M 0.00%
2022 28.98M 1.83%
2021 28.45M 15.77%
2020 24.58M 21.63%
2019 20.21M 11.87%
2018 18.06M 0.00%
2017 18.06M 0.00%
2016 18.06M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M 254.35%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B 868.92%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 603.22%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M 216.07%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US